Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) Sees Significant Drop in Short Interest

Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) saw a large drop in short interest in the month of March. As of March 15th, there was short interest totalling 541,500 shares, a drop of 47.9% from the February 28th total of 1,039,200 shares. Based on an average trading volume of 100 shares, the days-to-cover ratio is currently 5,415.0 days. Currently, 0.3% of the company’s shares are sold short.

Recordati Industria Chimica e Farmaceutica Stock Performance

OTCMKTS RCDTF remained flat at $55.54 during trading on Friday. The company has a market capitalization of $11.46 billion, a P/E ratio of 27.77 and a beta of 0.30. The business has a fifty day simple moving average of $55.54 and a 200-day simple moving average of $53.73. Recordati Industria Chimica e Farmaceutica has a 52-week low of $52.25 and a 52-week high of $52.25.

Recordati Industria Chimica e Farmaceutica Company Profile

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.